If you’re planning a trip abroad — particularly to countries with high rates of violence, disease, or both — you need to know about travel health insurance.
Paying an accounting professional can have benefits that far outweigh the added costs—but what happens if your accountant makes a mistake? If your accountant made a costly error and is unwilling to set things right, you should understand your legal rights and options.
Pharmaceutical companies approach new drugs with one question in mind: How do we make $1 billion? A compound’s path from initial approval to blockbuster drug typically follows these eleven steps.
Hacking of real estate transactions increased more than 50-fold last year. Learn how to protect yourself.
Bayer and Monsanto are trying to sell their proposed merger as being in the public interest, but the evidence simply doesn't support this claim. Here's why.
After stalling in the New York State Legislature for more than a decade, a bill that would help provide justice for child victims of sexual abuse is once again on the agenda.
Once again, governments are suing big companies to recoup the costs of a public health crisis caused by an addictive drug. But how do these lawsuits differ?
Lou Holtz has retained Morgan & Morgan’s Business Trial Group for a lawsuit against the Daily Beast alleging that the online publication damaged him by falsely reporting he disparaged immigrants during a 2016 speech.
Medical marijuana's moment may have arrived. Research supporting cannabis for pain relief has never been stronger, while opioid use has never looked riskier.
Thousands of investors in South Florida and nationally have been defrauded in a multi-billion dollar Ponzi scheme operated by Robert Shapiro and his Boca Raton-based Woodbridge Group of Companies, LLC.
The New York State Commission on Judicial Conduct is an eleven-member panel with authority to discipline judges of the New York courts. The Commission is constitutionally established to investigate and prosecute complaints filed against New York judges.
On October 4 the U.S. Senate Commerce Committee approved a bill that would get self-driving cars to market faster by loosening regulatory controls. The bill is similar to one the House of Representatives passed in September, allowing hundreds of thousands of autonomous vehicles per year on public roads.